5392682026-04-292026-04-295392682026-04-295392682026-04-29

ChangeInManagementDomain1

5392682026-04-292026-04-29

ChangeInManagementDomain1

5392682026-04-29

ChangeInManagementDomain2

5392682026-04-292026-04-29

ChangeInManagementDomain2

5392682026-04-29

ChangeInManagementDomain3

5392682026-04-292026-04-29

ChangeInManagementDomain3

xbrli:pure

SYNGENE

SYNGENE INTERNATIONAL LIMITED

539268

NOTLISTED

INE398R01022

true

Listed Entity (self)

true

2026-04-29

10:00:00

16:10:00

2026-04-29

Appointment

Director

Non - Executive Independent Director

Not Applicable

Mr.

Vijaya Chandru

2026-07-29

Vijaya Chandru is a leading academic-entrepreneur who has advanced deep-tech innovation in India for over 25 years. Trained in decision sciences (AI) with a PhD in Operations Research from Massachusetts Institute of Technology, his work spans optimization, geometry, logic, and computational biology. He co-founded Strand Life Sciences (2000), PicoPeta Simputers (2001), Yantri Labs Inc. (2018), and CRISPRBITS. He serves on the faculty at National Centre for Biological Sciences, Indian Institute of Science, and Harvard T.H. Chan School of Public Health, and has held tenured positions at Purdue University and IISc. In 2024, American Association for the Advancement of Science elected him Fellow for contributions to theoretical computer science, computational biology, and technology for social good. He was also named a Technology Pioneer by the World Economic Forum in 2006. Chandru leads the “No Disease Orphan by 2030” mission and co-chaired the technology workstream of the The Lancet Commission on Citizen-Centred Health Systems for India.

Not Applicable

true

false

Appointment

Director

Non - Executive Independent Director

Not Applicable

Mr.

Arun Chandavarkar

2026-07-29

Arun Chandavarkar retired as CEO & Joint Managing Director of Biocon Limited on 30 November 2019 after a 29-year career. During his tenure, Chandavarkar was instrumental in transforming Biocon from an enzymes business into a globally recognized biopharma company. He contributed to its 2004 IPO and led key initiatives including biologics partnerships, major R&D and infrastructure investments, divestment of the enzymes business, and organizational restructuring to support growth. He holds a B.Tech. in Chemical Engineering from Indian Institute of Technology Bombay and a PhD in Chemical Engineering from Massachusetts Institute of Technology. He is a former Chairperson of the biotechnology committee at Confederation of Indian Industry and serves as a non-executive director at Biocon Biologics and an independent director at Mynvax Private Limited.

Not Applicable

true

false

Appointment

Director

Non - Executive Non -Independent Director

Not Applicable

Ms.

Vinita Bali

2026-07-22

Ms. Bali is a global business leader with extensive experience in leading and transforming large companies both in India and overseas. She served as Chief Executive Officer & MD of Britannia Industries Ltd., from 2005 to 2014. Prior to that, she worked for The Coca-Cola Company and Cadbury Schweppes Plc in a variety of Marketing, General Management and Chief Executive roles in the UK, Nigeria, South Africa, USA and Chile. At present, she is a Non-Executive Director on the global boards of SATS Ltd and Cognizant Technology Solutions, and in India, she serves on the board of Bajaj Auto Limited. At Syngene, she is a member of the Nomination & Remuneration Committee, Audit Committee and the Corporate Social Responsibility Committee.

Not Applicable

true

false